Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 451-462
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.451
Table 1 Comparison of general information between the patient groups

IAI group (%)
Non-IAI group (%)
t/χ2
P value
Sample size1565
Gender
    Male11 (73.3)35 (53.8)1.8940.169
    Female4 (26.7)30 (46.2)
Age65.63 ± 13.0357.75 ± 12.86-2.1190.046
BMI24.05 ± 3.4722.94 ± 2.99-1.2570.212
Smoking history
    Yes6 (40.0)20 (30.8)0.4730.491
    No9 (60.0)45 (69.2)
Hypertension
    Yes10 (66.7)33 (50.8)1.2390.266
    No5 (33.3)32 (49.2)
Diabetes
    Yes8 (53.3)38 (58.5)0.1310.717
    No7 (46.7)27 (41.5)
Preoperative anemia
    Yes12 (80.0)47 (72.3)0.3730.542
    No3 (20.0)18 (27.7)
Tumor site
    Left8 (53.3)37 (56.9)0.0640.801
    Right7 (46.7)28 (43.1)
Degree of differentiation
Medium and above9 (60.0)30 (46.2)0.9350.334
Low6 (40.0)35 (53.8)
Infiltration depth
    T3 + T48 (53.3)38 (58.5)0.1310.717
    T1 + T27 (46.7)27 (41.5)
Tumor diameter (cm)4.69 ± 1.154.79 ± 1.210.2930.770
Lymphatic metastasis
    Yes6 (40.0)23 (35.4)0.1120.737
    No9 (60.0)42 (64.6)
Gross classification of tumor
    Ulcerative4 (26.7)13 (20.0)0.5000.868
    Wettability7 (46.7)31 (47.7)
    Uplift type4 (26.7)21 (32.3)
Intraoperative bleeding388.58 ± 59.27402.23 ± 57.110.8100.428